More on Lighthouse Pharma
2 known investors
Lighthouse Pharmaceuticals develops precision therapeutics for major unmet medical needs, with a lead program (LHP588), a gingipain inhibitor being tested in the Phase 2 SPRING trial for P. gingivalis-positive Alzheimer's disease. The company works in the biotechnology and drug development space, using patient responder analyses and dose modeling to advance its clinical candidates.
Investors · 2
Frequently asked questions
- What does More on Lighthouse Pharma do?
- Lighthouse Pharmaceuticals develops precision therapeutics for major unmet medical needs, with a lead program (LHP588), a gingipain inhibitor being tested in the Phase 2 SPRING trial for P. gingivalis-positive Alzheimer's disease. The company works in the biotechnology and drug development space, using patient responder analyses and dose modeling to advance its clinical candidates.
- Who are More on Lighthouse Pharma's investors?
- More on Lighthouse Pharma's investors include MSIV, Portfolia.